Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Trans Tasman Radiation Oncology Group (TROG)
Scientific Title
A Mulicentre Phase II clinical trial of STereotactic Ablative Body Radiotherapy for Primary Kidney Cancer